Abstract Lipoprotein (a)(Lp (a)) is associated with atherothrombosis through several
mechanisms, including putative antifibrinolytic properties. However, genetic association …

Abstract Lipoprotein (a)[Lp (a)] is a circulating lipoprotein, and its level is largely determined
by variation in the Lp (a) gene (LPA) locus encoding apo (a). Genetic variation in the LPA …

The leadership of the National Lipid Association convened an Expert Panel to develop a
consensus set of recommendations for patient-centered management of dyslipidemia in …

Abstract Background and Aims Ezetimibe reduces plasma low-density lipoprotein
cholesterol (LDL-C) levels by up to 20%. However, its effect on plasma lipoprotein (a)[Lp (a)] …

Robust associations between lipoprotein (a)[Lp (a)] and CVD outcomes among general
populations have been published in previous studies. However, associations in high risk …

Background Plasma concentrations of lipoprotein (a)(Lp (a)), a lipoprotein with atherogenic
and thrombogenic properties, have a strong genetic basis, although high concentrations of …

Background Lipoprotein (a) is a possible causal risk factor for atherosclerosis and related
complications. The distribution and prognostic implication of lipoprotein (a) in patients …

Background. Lipoprotein (a)(Lp (a)) is a genetic risk factor of atherosclerotic cardiovascular
diseases (ASCVDs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is related to …

Background Recently it has been demonstrated that elevated lipoprotein (a)(LPA) levels are
associated with an increased risk of cardiovascular disease across multiple ethnic groups …

Background Lipoprotein apheresis (LA) is the elective therapy for homozygous and other
forms of Familial Hypercholesterolemia, Familial Combined Hypercholesterolemia …